FDA Approves Raxibacumab for Treating Inhalable Anthrax

GlaxoSmithKline’s injectable drug. raxibacumab, has been approved by the US Food and Drug Administration for treating inhalable anthrax.

Inhalation of anthrax is seen as a major bioterrorism risk and is caused when people inhale spores of anthrax bacteria.

Anthrax - Bacillus - Symptoms - Diagnosis - Treatment - FAQs
Anthrax is caused by the bacterium Bacillus anthracis and spreads when the anthrax spores are inhaled, ingested, or come into contact with the skin lesion on a host.

Raxibacumab has been developed by GSK’s Human Genome Sciences and is a man-made protein that works by mimicking the naturally produced antibodies and blocks the toxins produced by the anthrax bacteria

Source-Medindia

Mr. Norris's Home Certified Anthrax-free
NHS Borders has confirmed that no traces of anthrax have been found at Mr.Norris's home but minute traces of anthrax have been found in other properties

For an Anthrax Free Smailholm, Decontamination Operation Begins
Remanence of anthrax spores in Smailholm and the border areas has raised the concern of NHS Borders, instigating a decontamination operation at a village hall

Physicists Unite To Develop Anthrax Detection Method
Physicists have joined forces to perfect a powerful new weapon in the war on terrorism – a laser technique to identify deadly anthrax spores.